SC 13G
SABBY 13G CANF 3.13.18
- Company
- Can-Fite BioPharma Ltd.
- Filed
- March 13, 2018
- Accession Number
- 0001535610-18-000066
A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →